RE: Hangover19 Oct 2023 07:20
Agree, however I think the point a made by someone earlier, its the consultants that will drive adoption.. I see BUPA looing at this a a way of refining spend on very expensive treatments, I have no idea how many patient in Bupa will be eligible for this test, but its clear BUPA will offer to all that are..In my mind this has massively derisked the whole venture, Burn just under £1million a month at aprilwas concerning , but 97 tests a month bring in £200k + month almost 80% margin ? , that was 4 months ago , the consultant network had doubled by april and network has expanded, all have a delayed positive effect .. cant wait for the updates of test progress, but if its doubled over the last 4 months then OBD is on a clear path to massive growth. One concern is that cost for PSA launch will get through cash and OBD is not well funded , so a placing is possible, but i dont think that will be an issu of massively dilutive as there is alot that the market hasnt had time to process yet.